| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.687 | 0.003 | 0.687 | Dopamine D5 antagonist | 0.612 0.003 DBMET00264 0.644 0.003 DBMET00265 0.542 0.003 DBMET00308 | ||
| 0.534 | 0.003 | 0.534 | Acetylcholine M4 receptor antagonist | 0.277 0.004 DBMET00264 0.4 0.003 DBMET00265 0.394 0.004 DBMET00308 | ||
| 0.512 | 0.003 | 0.654 | Dopamine D1 antagonist | 0.654 0.003 DBMET00264 0.338 0.005 DBMET00265 0.43 0.004 DBMET00308 | DBMET00264 | |
| 0.509 | 0.007 | 0.509 | 5 Hydroxytryptamine antagonist | 0.305 0.018 DBMET00264 0.389 0.012 DBMET00265 0.277 0.021 DBMET00308 | ||
| 0.504 | 0.006 | 0.504 | 5 Hydroxytryptamine 2 antagonist | 0.361 0.012 DBMET00264 0.423 0.009 DBMET00265 0.369 0.011 DBMET00308 | ||
| 0.5 | 0.004 | 0.5 | 5 Hydroxytryptamine 1F antagonist | 0.322 0.005 DBMET00264 0.462 0.004 DBMET00265 0.404 0.005 DBMET00308 | ||
| 0.497 | 0.003 | 0.497 | 5 Hydroxytryptamine 3 antagonist | 0.232 0.005 DBMET00264 0.362 0.004 DBMET00265 0.151 0.009 DBMET00308 | ||
| 0.49 | 0.021 | 0.499 | MAP kinase kinase 6 inhibitor | 0.449 0.035 DBMET00264 0.499 0.019 DBMET00265 0.382 0.07 DBMET00308 0.337 0.103 DBMET02401 | DBMET00265 | |
| 0.465 | 0.006 | 0.465 | Dopamine antagonist | 0.427 0.007 DBMET00264 0.295 0.012 DBMET00265 0.189 0.02 DBMET00308 | ||
| 0.459 | 0.004 | 0.459 | Alpha 2a adrenoreceptor antagonist | 0.443 0.004 DBMET00264 0.413 0.005 DBMET00265 0.316 0.006 DBMET00308 | ||
| 0.455 | 0.004 | 0.455 | Dopamine D4 antagonist | 0.345 0.005 DBMET00264 0.229 0.01 DBMET00265 0.145 0.018 DBMET00308 | ||
| 0.456 | 0.006 | 0.456 | 5 Hydroxytryptamine 2B antagonist | 0.357 0.011 DBMET00264 0.386 0.009 DBMET00265 0.418 0.008 DBMET00308 | ||
| 0.45 | 0.005 | 0.45 | 5 Hydroxytryptamine 2A antagonist | 0.309 0.011 DBMET00264 0.364 0.008 DBMET00265 0.183 0.022 DBMET00308 | ||
| 0.445 | 0.002 | 0.445 | 5 Hydroxytryptamine 3A antagonist | 0.245 0.003 DBMET00264 0.383 0.002 DBMET00265 0.183 0.004 DBMET00308 | ||
| 0.445 | 0.004 | 0.445 | Alpha 1 adrenoreceptor agonist | 0.413 0.004 DBMET00264 0.382 0.004 DBMET00265 0.156 0.009 DBMET00308 | ||
| 0.398 | 0.005 | 0.398 | Alpha 2 adrenoreceptor antagonist | 0.347 0.006 DBMET00264 0.359 0.006 DBMET00265 0.265 0.01 DBMET00308 | ||
| 0.447 | 0.055 | 0.557 | 15-Lipoxygenase inhibitor | 0.557 0.031 DBMET00264 0.394 0.077 DBMET00265 0.219 0.193 DBMET00308 | DBMET00264 | |
| 0.373 | 0.005 | 0.373 | Alpha 2b adrenoreceptor antagonist | 0.336 0.007 DBMET00264 0.333 0.007 DBMET00265 0.139 0.044 DBMET00308 | ||
| 0.369 | 0.007 | 0.369 | Acetylcholine M1 receptor antagonist | 0.341 0.009 DBMET00264 0.291 0.016 DBMET00265 0.313 0.012 DBMET00308 0.197 0.044 DBMET02401 | ||
| 0.367 | 0.008 | 0.367 | Dopamine D2 antagonist | 0.34 0.009 DBMET00264 0.233 0.014 DBMET00265 0.156 0.022 DBMET00308 | ||
| 0.345 | 0.006 | 0.345 | Alpha 1b adrenoreceptor antagonist | 0.305 0.007 DBMET00264 0.284 0.008 DBMET00265 0.26 0.009 DBMET00308 | ||
| 0.339 | 0.004 | 0.343 | Alpha adrenoreceptor agonist | 0.33 0.004 DBMET00264 0.343 0.004 DBMET00265 0.129 0.02 DBMET00308 | DBMET00265 | |
| 0.423 | 0.092 | 0.423 | MAP kinase 1 inhibitor | 0.406 0.102 DBMET00264 0.33 0.151 DBMET00265 0.247 0.237 DBMET00308 | ||
| 0.317 | 0.005 | 0.317 | GABA receptor agonist | 0.242 0.011 DBMET00264 0.287 0.007 DBMET00265 0.162 0.03 DBMET00308 | ||
| 0.329 | 0.033 | 0.329 | Anticonvulsant | 0.152 0.127 DBMET00264 0.243 0.06 DBMET00265 0.143 0.138 DBMET00308 0.158 0.12 DBMET02401 | ||
| 0.288 | 0.003 | 0.288 | 5 Hydroxytryptamine 6 antagonist | 0.161 0.005 DBMET00264 0.253 0.003 DBMET00265 0.149 0.006 DBMET00308 | ||
| 0.29 | 0.005 | 0.29 | 5 Hydroxytryptamine 1B antagonist | 0.158 0.012 DBMET00264 0.188 0.009 DBMET00265 0.148 0.013 DBMET00308 | ||
| 0.315 | 0.034 | 0.361 | Death-associated protein kinase 3 inhibitor | 0.26 0.049 DBMET00264 0.361 0.024 DBMET00265 0.226 0.062 DBMET00308 | DBMET00265 | |
| 0.296 | 0.016 | 0.296 | Alpha adrenoreceptor antagonist | 0.26 0.019 DBMET00264 0.254 0.02 DBMET00265 0.214 0.025 DBMET00308 | ||
| 0.298 | 0.026 | 0.346 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.253 0.036 DBMET00264 0.346 0.016 DBMET00265 0.22 0.044 DBMET00308 | DBMET00265 | |
| 0.287 | 0.019 | 0.314 | Protein kinase (CK1) inhibitor | 0.187 0.045 DBMET00264 0.314 0.016 DBMET00265 0.156 0.063 DBMET00308 | DBMET00265 | |
| 0.377 | 0.122 | 0.39 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.39 0.109 DBMET00265 0.273 0.252 DBMET00308 | DBMET00265 | |
| 0.259 | 0.004 | 0.259 | Acetylcholine M5 receptor antagonist | 0.188 0.005 DBMET00264 0.18 0.005 DBMET00265 0.14 0.009 DBMET00308 | ||
| 0.285 | 0.04 | 0.285 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.243 0.053 DBMET00264 0.239 0.055 DBMET00265 0.213 0.067 DBMET00308 | ||
| 0.268 | 0.028 | 0.272 | I kappa B kinase epsilon inhibitor | 0.272 0.027 DBMET00264 0.261 0.032 DBMET00265 0.237 0.045 DBMET00308 | DBMET00264 | |
| 0.241 | 0.011 | 0.241 | Alpha 2c adrenoreceptor antagonist | 0.219 0.014 DBMET00264 0.206 0.017 DBMET00265 0.122 0.048 DBMET00308 | ||
| 0.238 | 0.009 | 0.238 | 5 Hydroxytryptamine 7 antagonist | 0.156 0.017 DBMET00264 0.231 0.009 DBMET00265 0.087 0.028 DBMET00308 | ||
| 0.231 | 0.004 | 0.231 | Histamine agonist | 0.09 0.011 DBMET00264 0.161 0.005 DBMET00265 0.07 0.019 DBMET00308 | ||
| 0.271 | 0.047 | 0.274 | MAP-kinase-activated kinase 5 inhibitor | 0.266 0.05 DBMET00264 0.274 0.045 DBMET00265 0.211 0.09 DBMET00308 0.176 0.139 DBMET02401 | DBMET00265 | |
| 0.232 | 0.011 | 0.232 | Histamine H1 receptor antagonist | 0.12 0.032 DBMET00264 0.141 0.027 DBMET00265 0.225 0.012 DBMET00308 | ||
| 0.227 | 0.01 | 0.227 | Acetylcholine agonist | 0.128 0.034 DBMET00264 0.204 0.013 DBMET00265 0.171 0.02 DBMET00308 | ||
| 0.301 | 0.085 | 0.38 | Apoptosis antagonist | 0.324 0.07 DBMET00264 0.304 0.083 DBMET00265 0.258 0.12 DBMET00308 0.38 0.044 DBMET02401 | DBMET02401 | |
| 0.287 | 0.074 | 0.287 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.282 0.078 DBMET00264 0.261 0.096 DBMET00265 | ||
| 0.223 | 0.015 | 0.223 | 5 Hydroxytryptamine 2C antagonist | 0.144 0.028 DBMET00264 0.183 0.02 DBMET00265 0.12 0.036 DBMET00308 | ||
| 0.21 | 0.004 | 0.232 | Alpha 2 adrenoreceptor agonist | 0.178 0.005 DBMET00264 0.232 0.004 DBMET00265 0.083 0.022 DBMET00308 | DBMET00265 | |
| 0.255 | 0.049 | 0.436 | Platelet aggregation inhibitor | 0.26 0.047 DBMET00264 0.26 0.048 DBMET00265 0.18 0.098 DBMET00308 0.436 0.015 DBMET02401 | DBMET02401 | |
| 0.243 | 0.042 | 0.243 | LIM domain kinase 1 inhibitor | 0.2 0.063 DBMET00264 0.239 0.044 DBMET00265 0.145 0.103 DBMET00308 | ||
| 0.21 | 0.01 | 0.21 | Dopamine D3 antagonist | 0.152 0.015 DBMET00264 0.118 0.02 DBMET00265 0.065 0.04 DBMET00308 | ||
| 0.241 | 0.049 | 0.283 | CDC-like kinase 4 inhibitor | 0.177 0.081 DBMET00264 0.283 0.036 DBMET00265 0.144 0.106 DBMET00308 | DBMET00265 | |
| 0.21 | 0.019 | 0.21 | Alpha 1 adrenoreceptor antagonist | 0.18 0.024 DBMET00264 0.189 0.022 DBMET00265 0.139 0.032 DBMET00308 | ||
| 0.199 | 0.01 | 0.199 | Alpha 1d adrenoreceptor antagonist | 0.16 0.013 DBMET00264 0.178 0.011 DBMET00265 0.12 0.019 DBMET00308 | ||
| 0.247 | 0.069 | 0.255 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.21 0.139 DBMET00264 0.255 0.059 DBMET00265 0.235 0.086 DBMET00308 | DBMET00265 | |
| 0.199 | 0.025 | 0.201 | Acetylcholine muscarinic antagonist | 0.173 0.033 DBMET00264 0.155 0.041 DBMET00265 0.201 0.024 DBMET00308 | DBMET00308 | |
| 0.205 | 0.033 | 0.205 | Toll-Like receptor 9 antagonist | 0.182 0.044 DBMET00264 0.146 0.066 DBMET00265 0.116 0.09 DBMET00308 | ||
| 0.205 | 0.035 | 0.226 | Ribosomal protein S6 kinase inhibitor | 0.179 0.047 DBMET00264 0.226 0.028 DBMET00265 0.114 0.097 DBMET00308 | DBMET00265 | |
| 0.229 | 0.065 | 0.229 | MAP kinase kinase 2 inhibitor | 0.222 0.068 DBMET00264 0.205 0.079 DBMET00265 | ||
| 0.193 | 0.031 | 0.193 | Protein kinase (CK1) delta inhibitor | 0.137 0.061 DBMET00264 0.191 0.032 DBMET00265 0.106 0.085 DBMET00308 | ||
| 0.23 | 0.071 | 0.23 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.185 0.103 DBMET00264 0.206 0.086 DBMET00265 0.162 0.128 DBMET00308 | ||
| 0.313 | 0.155 | 0.393 | DNA directed DNA polymerase inhibitor | 0.312 0.156 DBMET00264 0.255 0.188 DBMET00265 0.393 0.118 DBMET02401 | DBMET02401 | |
| 0.192 | 0.034 | 0.209 | Cholinergic antagonist | 0.167 0.044 DBMET00264 0.157 0.049 DBMET00265 0.209 0.03 DBMET00308 | DBMET00308 | |
| 0.19 | 0.033 | 0.207 | Acetylcholine antagonist | 0.165 0.043 DBMET00264 0.154 0.048 DBMET00265 0.207 0.029 DBMET00308 | DBMET00308 | |
| 0.27 | 0.117 | 0.277 | Prostaglandin dehydrogenase inhibitor | 0.269 0.117 DBMET00264 0.277 0.113 DBMET00265 | DBMET00265 | |
| 0.22 | 0.068 | 0.234 | Clk dual-specificity kinase inhibitor | 0.182 0.09 DBMET00264 0.234 0.062 DBMET00265 | DBMET00265 | |
| 0.234 | 0.088 | 0.387 | Aldehyde oxidase inhibitor | 0.387 0.049 DBMET00264 0.148 0.141 DBMET00265 0.235 0.088 DBMET00308 | DBMET00264 | |
| 0.236 | 0.09 | 0.236 | 5 Hydroxytryptamine 1E antagonist | 0.2 0.131 DBMET00264 | ||
| 0.145 | 0.005 | 0.145 | 5 Hydroxytryptamine 3 agonist | 0.115 0.01 DBMET00264 0.122 0.008 DBMET00265 0.118 0.009 DBMET00308 | ||
| 0.208 | 0.071 | 0.211 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.17 0.096 DBMET00264 0.211 0.07 DBMET00265 | DBMET00265 | |
| 0.214 | 0.079 | 0.214 | EphB2 antagonist | 0.207 0.083 DBMET00264 0.168 0.113 DBMET00265 | ||
| 0.187 | 0.053 | 0.187 | Polo-like kinase-3 inhibitor | 0.166 0.069 DBMET00264 0.151 0.083 DBMET00265 0.154 0.079 DBMET00308 | ||
| 0.145 | 0.012 | 0.145 | Acetylcholine M2 receptor antagonist | 0.11 0.019 DBMET00264 0.095 0.023 DBMET00265 0.059 0.046 DBMET00308 | ||
| 0.148 | 0.018 | 0.148 | Phosphodiesterase I inhibitor | 0.123 0.026 DBMET00264 0.1 0.045 DBMET00265 0.095 0.051 DBMET00308 0.087 0.064 DBMET02401 | ||
| 0.138 | 0.008 | 0.138 | Phosphodiesterase 1B inhibitor | 0.106 0.013 DBMET00264 0.091 0.017 DBMET00265 0.074 0.027 DBMET00308 | ||
| 0.154 | 0.031 | 0.154 | Antihistaminic | 0.095 0.059 DBMET00265 0.139 0.035 DBMET00308 | ||
| 0.149 | 0.027 | 0.149 | Gastric antisecretory | 0.132 0.036 DBMET00264 0.134 0.034 DBMET00265 | ||
| 0.133 | 0.012 | 0.133 | Benzodiazepine agonist | 0.072 0.048 DBMET00264 0.102 0.024 DBMET00265 0.072 0.048 DBMET00308 | ||
| 0.228 | 0.107 | 0.228 | Gastrin inhibitor | 0.223 0.114 DBMET00308 | ||
| 0.135 | 0.014 | 0.15 | Alpha 2d adrenoreceptor antagonist | 0.118 0.025 DBMET00264 0.15 0.009 DBMET00265 | DBMET00265 | |
| 0.153 | 0.034 | 0.164 | 5 Hydroxytryptamine 3A agonist | 0.112 0.063 DBMET00264 0.164 0.028 DBMET00265 | DBMET00265 | |
| 0.141 | 0.025 | 0.141 | 5 Hydroxytryptamine 1 antagonist | 0.086 0.044 DBMET00264 0.091 0.04 DBMET00265 | ||
| 0.287 | 0.172 | 0.287 | DNA polymerase beta inhibitor | 0.28 0.176 DBMET00264 0.231 0.204 DBMET00265 | ||
| 0.15 | 0.036 | 0.174 | Antiadrenergic | 0.141 0.039 DBMET00264 0.174 0.03 DBMET00265 0.138 0.039 DBMET00308 | DBMET00265 | |
| 0.148 | 0.035 | 0.172 | Adrenaline antagonist | 0.139 0.038 DBMET00264 0.172 0.029 DBMET00265 0.136 0.039 DBMET00308 | DBMET00265 | |
| 0.143 | 0.031 | 0.143 | Histamine antagonist | 0.084 0.059 DBMET00265 0.125 0.037 DBMET00308 | ||
| 0.119 | 0.007 | 0.18 | 5 Hydroxytryptamine 2 agonist | 0.077 0.016 DBMET00264 0.18 0.004 DBMET00265 0.068 0.02 DBMET00308 | DBMET00265 | |
| 0.281 | 0.17 | 0.37 | Alpha-glucosidase inhibitor | 0.37 0.127 DBMET00264 0.274 0.174 DBMET00265 | DBMET00264 | |
| 0.116 | 0.004 | 0.116 | Histamine H4 receptor antagonist | 0.058 0.021 DBMET00264 0.084 0.007 DBMET00265 0.079 0.009 DBMET00308 | ||
| 0.113 | 0.004 | 0.113 | 5 Hydroxytryptamine 3B antagonist | 0.05 0.014 DBMET00264 0.074 0.008 DBMET00265 0.044 0.018 DBMET00308 | ||
| 0.155 | 0.053 | 0.168 | MAP3K9 inhibitor | 0.15 0.06 DBMET00264 0.158 0.049 DBMET00265 0.168 0.037 DBMET00308 | DBMET00308 | |
| 0.197 | 0.095 | 0.197 | Potassium channel blocker | 0.18 0.107 DBMET00265 | ||
| 0.122 | 0.025 | 0.122 | 5 Hydroxytryptamine 1A antagonist | 0.082 0.039 DBMET00264 0.095 0.034 DBMET00265 | ||
| 0.105 | 0.01 | 0.105 | Phosphodiesterase VII inhibitor | 0.086 0.02 DBMET00264 0.105 0.01 DBMET00265 0.091 0.017 DBMET00308 | ||
| 0.099 | 0.004 | 0.099 | Protein kinase (CK1) epsilon inhibitor | 0.044 0.02 DBMET00264 0.09 0.004 DBMET00265 0.042 0.022 DBMET00308 | ||
| 0.134 | 0.039 | 0.186 | Check point kinase 2 inhibitor | 0.118 0.051 DBMET00264 0.186 0.02 DBMET00265 0.106 0.06 DBMET00308 | DBMET00265 | |
| 0.123 | 0.03 | 0.157 | Protein kinase C zeta inhibitor | 0.157 0.018 DBMET00264 0.105 0.045 DBMET00265 0.121 0.032 DBMET00308 | DBMET00264 | |
| 0.117 | 0.029 | 0.219 | 5 Hydroxytryptamine agonist | 0.219 0.013 DBMET00265 0.106 0.032 DBMET00308 | DBMET00265 | |
| 0.109 | 0.024 | 0.124 | Dopamine agonist | 0.124 0.019 DBMET00264 0.084 0.035 DBMET00265 0.064 0.049 DBMET00308 | DBMET00264 | |
| 0.188 | 0.105 | 0.243 | Dyrk kinase inhibitor | 0.243 0.075 DBMET00264 0.186 0.106 DBMET00265 | DBMET00264 | |
| 0.09 | 0.009 | 0.09 | Potassium channel (Inward rectifier) blocker | 0.055 0.028 DBMET00264 0.082 0.012 DBMET00265 0.082 0.012 DBMET00308 | ||
| 0.148 | 0.068 | 0.148 | Activin receptor-like kinase 2 inhibitor | 0.117 0.1 DBMET00264 0.147 0.069 DBMET00265 | ||
| 0.112 | 0.032 | 0.112 | Alpha 1a adrenoreceptor antagonist | 0.09 0.04 DBMET00264 0.104 0.034 DBMET00265 0.069 0.051 DBMET00308 | ||
| 0.085 | 0.005 | 0.112 | Purinergic P2T antagonist | 0.053 0.009 DBMET00264 0.095 0.005 DBMET00265 0.083 0.006 DBMET00308 0.112 0.005 DBMET02401 | DBMET02401 | |
| 0.215 | 0.14 | 0.215 | Nootropic | 0.204 0.152 DBMET00265 | ||
| 0.094 | 0.02 | 0.141 | Protein kinase C iota inhibitor | 0.067 0.034 DBMET00264 0.141 0.01 DBMET00265 | DBMET00265 | |
| 0.133 | 0.061 | 0.133 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.107 0.075 DBMET00264 0.111 0.073 DBMET00265 | ||
| 0.08 | 0.01 | 0.093 | Gonadotropin-releasing hormone receptor antagonist | 0.049 0.017 DBMET00264 0.093 0.008 DBMET00265 0.058 0.014 DBMET00308 | DBMET00265 | |
| 0.076 | 0.008 | 0.076 | Phosphodiesterase 7A inhibitor | 0.066 0.014 DBMET00264 0.076 0.008 DBMET00265 0.069 0.012 DBMET00308 | ||
| 0.128 | 0.061 | 0.151 | MAP kinase 12 inhibitor | 0.103 0.093 DBMET00264 0.151 0.041 DBMET00265 | DBMET00265 | |
| 0.11 | 0.043 | 0.11 | mTOR complex 1 inhibitor | 0.098 0.067 DBMET00264 0.106 0.051 DBMET00265 0.102 0.058 DBMET00308 | ||
| 0.145 | 0.079 | 0.162 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.162 0.064 DBMET00264 0.15 0.074 DBMET00265 | DBMET00264 | |
| 0.178 | 0.112 | 0.181 | 5 Hydroxytryptamine 3E antagonist | 0.181 0.104 DBMET00265 | DBMET00265 | |
| 0.124 | 0.06 | 0.138 | Protein kinase (CK2) alpha inhibitor | 0.119 0.063 DBMET00264 0.138 0.049 DBMET00265 | DBMET00265 | |
| 0.178 | 0.116 | 0.178 | Aryl hydrocarbon receptor agonist | 0.169 0.122 DBMET00264 0.153 0.133 DBMET00265 | ||
| 0.08 | 0.021 | 0.08 | Cyclin-dependent kinase 6 inhibitor | 0.054 0.049 DBMET00264 0.08 0.022 DBMET00265 0.062 0.039 DBMET00308 | ||
| 0.195 | 0.137 | 0.195 | MAP kinase kinase 3 inhibitor | 0.194 0.139 DBMET00265 | ||
| 0.148 | 0.09 | 0.148 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.13 0.105 DBMET00264 | ||
| 0.119 | 0.064 | 0.119 | Platelet activating factor antagonist | 0.114 0.067 DBMET00264 | ||
| 0.085 | 0.029 | 0.096 | Purinergic P2 antagonist | 0.096 0.023 DBMET00265 0.09 0.026 DBMET02401 | DBMET00265 | |
| 0.11 | 0.055 | 0.125 | Protein kinase (CK2) inhibitor | 0.105 0.06 DBMET00264 0.125 0.045 DBMET00265 | DBMET00265 | |
| 0.056 | 0.006 | 0.09 | Purinergic P2Y12 antagonist | 0.037 0.009 DBMET00264 0.055 0.006 DBMET00265 0.053 0.006 DBMET00308 0.09 0.004 DBMET02401 | DBMET02401 | |
| 0.227 | 0.176 | 0.281 | GABA C receptor rho-3 antagonist | 0.281 0.129 DBMET00264 | DBMET00264 | |
| 0.166 | 0.117 | 0.225 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.225 0.079 DBMET00264 0.164 0.119 DBMET00265 | DBMET00264 | |
| 0.097 | 0.049 | 0.128 | Pim-3 kinase inhibitor | 0.128 0.026 DBMET00265 | DBMET00265 | |
| 0.111 | 0.065 | 0.111 | Polo-like kinase-4 inhibitor | 0.093 0.084 DBMET00264 0.092 0.085 DBMET00308 | ||
| 0.074 | 0.029 | 0.079 | Acetylcholine M3 receptor antagonist | 0.079 0.027 DBMET00264 0.065 0.035 DBMET00265 0.059 0.042 DBMET00308 | DBMET00264 | |
| 0.111 | 0.065 | 0.136 | Activin receptor-like kinase 4 inhibitor | 0.136 0.037 DBMET00265 | DBMET00265 | |
| 0.102 | 0.058 | 0.102 | Insulin receptor antagonist | |||
| 0.079 | 0.035 | 0.124 | Adenosine A2 receptor antagonist | 0.057 0.052 DBMET00264 0.124 0.021 DBMET02401 | DBMET02401 | |
| 0.099 | 0.057 | 0.138 | Protein kinase C mu inhibitor | 0.091 0.066 DBMET00264 0.138 0.032 DBMET00265 0.084 0.075 DBMET00308 0.091 0.066 DBMET02401 | DBMET00265 | |
| 0.086 | 0.046 | 0.086 | Transforming growth factor beta 3 antagonist | 0.085 0.049 DBMET00265 | ||
| 0.122 | 0.083 | 0.15 | Glycogen synthase kinase-3 alpha inhibitor | 0.114 0.089 DBMET00264 0.15 0.067 DBMET00265 | DBMET00265 | |
| 0.05 | 0.011 | 0.05 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET00265 | ||
| 0.111 | 0.072 | 0.111 | Aurora-B kinase inhibitor | 0.105 0.076 DBMET00265 | ||
| 0.046 | 0.008 | 0.046 | CDK4/cyclin D3 inhibitor | 0.029 0.019 DBMET00264 0.045 0.008 DBMET00265 | ||
| 0.072 | 0.035 | 0.131 | Adenosine A2a receptor antagonist | 0.06 0.044 DBMET00264 0.131 0.018 DBMET02401 | DBMET02401 | |
| 0.217 | 0.184 | 0.266 | Histamine release inhibitor | 0.266 0.144 DBMET00264 0.25 0.155 DBMET00308 0.204 0.197 DBMET02401 | DBMET00264 | |
| 0.231 | 0.2 | 0.231 | Transcription factor inhibitor | |||
| 0.114 | 0.085 | 0.217 | DNA repair enzyme inhibitor | 0.116 0.081 DBMET00264 0.163 0.022 DBMET00308 0.217 0.007 DBMET02401 | DBMET02401 | |
| 0.043 | 0.014 | 0.043 | Acetylcholine M4 receptor agonist | 0.032 0.02 DBMET00265 | ||
| 0.065 | 0.036 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | 0.06 0.047 DBMET00265 | ||
| 0.083 | 0.056 | 0.097 | I kappa B kinase inhibitor | 0.075 0.069 DBMET00264 0.097 0.041 DBMET00265 0.093 0.045 DBMET00308 | DBMET00265 | |
| 0.063 | 0.036 | 0.069 | Glutamate (mGluR1) antagonist | 0.069 0.031 DBMET00265 | DBMET00265 | |
| 0.038 | 0.013 | 0.052 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.052 0.009 DBMET00265 | DBMET00265 | |
| 0.035 | 0.01 | 0.036 | Potassium channel (Inward rectifier) 1 blocker | 0.029 0.024 DBMET00264 0.034 0.012 DBMET00265 0.036 0.01 DBMET00308 | DBMET00308 | |
| 0.067 | 0.044 | 0.096 | Cyclin-dependent kinase 4 inhibitor | 0.096 0.027 DBMET00265 | DBMET00265 | |
| 0.189 | 0.166 | 0.403 | Hypoxia-inducible factor 1 alpha inhibitor | 0.246 0.105 DBMET00264 0.197 0.156 DBMET00265 0.276 0.079 DBMET00308 0.403 0.029 DBMET02401 | DBMET02401 | |
| 0.059 | 0.038 | 0.062 | Protein kinase C theta inhibitor | 0.062 0.033 DBMET00265 | DBMET00265 | |
| 0.149 | 0.132 | 0.149 | HERG channel blocker | |||
| 0.061 | 0.045 | 0.073 | I kappa B kinase 2 inhibitor | 0.073 0.029 DBMET00265 0.067 0.036 DBMET00308 | DBMET00265 | |
| 0.065 | 0.049 | 0.089 | CDC7 inhibitor | 0.089 0.03 DBMET00265 | DBMET00265 | |
| 0.085 | 0.07 | 0.085 | Fibroblast growth factor 1 antagonist | |||
| 0.09 | 0.075 | 0.09 | Aurora-A kinase inhibitor | |||
| 0.023 | 0.009 | 0.023 | Histamine H4 receptor agonist | |||
| 0.156 | 0.142 | 0.42 | Cyclic AMP phosphodiesterase inhibitor | 0.157 0.141 DBMET00264 0.167 0.126 DBMET00308 0.42 0.014 DBMET02401 | DBMET02401 | |
| 0.141 | 0.128 | 0.194 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.194 0.081 DBMET00265 | DBMET00265 | |
| 0.044 | 0.033 | 0.044 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.13 | 0.12 | 0.13 | TRKC antagonist | |||
| 0.057 | 0.047 | 0.057 | Cyclin A inhibitor | 0.054 0.049 DBMET00265 | ||
| 0.042 | 0.034 | 0.131 | 5 Hydroxytryptamine 2C agonist | 0.131 0.005 DBMET00265 | DBMET00265 | |
| 0.046 | 0.039 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.031 DBMET00264 | DBMET00264 | |
| 0.068 | 0.062 | 0.116 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.071 0.059 DBMET00264 0.116 0.029 DBMET00265 | DBMET00265 | |
| 0.076 | 0.07 | 0.077 | Bcr-Abl kinase inhibitor | 0.077 0.068 DBMET00308 | DBMET00308 | |
| 0.021 | 0.015 | 0.03 | Glutaminyl-peptide cyclotransferase inhibitor | 0.03 0.006 DBMET00265 | DBMET00265 | |
| 0.055 | 0.05 | 0.061 | Cyclin A1 inhibitor | 0.061 0.036 DBMET00265 | DBMET00265 | |
| 0.076 | 0.071 | 0.076 | GABA A receptor agonist | 0.076 0.071 DBMET00265 | ||
| 0.05 | 0.045 | 0.05 | Lysine-specific demethylase 1A inhibitor | |||
| 0.01 | 0.006 | 0.01 | CXC chemokine 3 receptor agonist | 0.009 0.008 DBMET00265 | ||
| 0.016 | 0.012 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.013 DBMET00265 | ||
| 0.08 | 0.077 | 0.103 | Protein kinase C delta inhibitor | 0.103 0.05 DBMET00265 | DBMET00265 | |
| 0.081 | 0.078 | 0.081 | Platelet activating factor beta antagonist | 0.081 0.078 DBMET00264 | ||
| 0.094 | 0.091 | 0.114 | MAP kinase 13 inhibitor | 0.114 0.062 DBMET00265 | DBMET00265 | |
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.159 | 0.158 | 0.202 | ErbB-1 antagonist | 0.202 0.087 DBMET00264 | DBMET00264 | |
| 0.049 | 0.05 | 0.277 | Adenosine A1 receptor antagonist | 0.277 0.007 DBMET02401 | DBMET02401 | |
| 0.109 | 0.115 | 0.455 | Cytidine deaminase inhibitor | 0.455 0.007 DBMET02401 | DBMET02401 | |
| 0.017 | 0.025 | 0.024 | Alpha 2d adrenoreceptor agonist | 0.024 0.012 DBMET00265 | DBMET00265 | |
| 0.058 | 0.067 | 0.073 | Protein kinase B alpha inhibitor | 0.073 0.045 DBMET00265 | DBMET00265 | |
| 0.14 | 0.152 | 0.146 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.146 0.141 DBMET00264 | DBMET00264 | |
| 0.07 | 0.084 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.027 DBMET00264 0.086 0.031 DBMET00265 0.078 0.052 DBMET00308 | DBMET00264 | |
| 0.117 | 0.132 | 0.124 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.124 0.122 DBMET00265 | DBMET00265 | |
| 0.1 | 0.116 | 0.173 | Lipid peroxidase inhibitor | 0.173 0.054 DBMET00264 | DBMET00264 | |
| 0.063 | 0.081 | 0.08 | Platelet growth factor antagonist | 0.08 0.056 DBMET00264 | DBMET00264 | |
| 0.115 | 0.133 | 0.135 | Death-associated protein kinase 1 inhibitor | 0.135 0.069 DBMET00265 | DBMET00265 | |
| 0.123 | 0.145 | 0.186 | Pyruvate kinase inhibitor | 0.186 0.089 DBMET00264 | DBMET00264 | |
| 0.041 | 0.065 | 0.063 | Myc inhibitor | 0.063 0.026 DBMET00265 | DBMET00265 | |
| 0.055 | 0.081 | 0.08 | Rho-associated kinase I inhibitor | 0.08 0.046 DBMET00265 | DBMET00265 | |
| 0.027 | 0.058 | 0.176 | Purinergic P2Y antagonist | 0.176 0.004 DBMET02401 | DBMET02401 | |
| 0.047 | 0.089 | 0.073 | Check point kinase 1 inhibitor | 0.073 0.043 DBMET00265 | DBMET00265 | |
| 0.123 | 0.169 | 0.181 | Heat shock protein 70 antagonist | 0.181 0.011 DBMET02401 | DBMET02401 | |
| 0.055 | 0.106 | 0.097 | Adrenaline agonist | 0.097 0.039 DBMET00264 0.081 0.057 DBMET00265 | DBMET00264 | |
| 0.163 | 0.218 | 0.194 | Tyrosine 3 hydroxylase inhibitor | 0.194 0.147 DBMET00264 | DBMET00264 | |
| 0.045 | 0.101 | 0.087 | Protein kinase C beta inhibitor | 0.087 0.021 DBMET00308 | DBMET00308 | |
| 0.06 | 0.118 | 0.091 | Pim-1 kinase inhibitor | 0.091 0.067 DBMET00265 | DBMET00265 | |
| 0.037 | 0.106 | 0.062 | Glucosylceramidase inhibitor | 0.062 0.028 DBMET00265 | DBMET00265 | |
| 0.173 | 0.259 | 0.261 | Calcium channel activator | 0.261 0.134 DBMET00265 | DBMET00265 | |
| 0.091 | 0.196 | 0.361 | Platelet adhesion inhibitor | 0.146 0.111 DBMET00265 0.361 0.017 DBMET02401 | DBMET02401 | |
| 0.182 | 0.303 | 0.425 | Cyclophilin D inhibitor | 0.253 0.209 DBMET00265 0.324 0.142 DBMET00308 0.425 0.077 DBMET02401 | DBMET02401 | |
| 0.005 | 0.133 | 0.021 | Adenosine kinase inhibitor | 0.021 0.015 DBMET02401 | DBMET02401 | |
| 0.08 | 0.212 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.096 DBMET00265 | DBMET00265 | |
| 0.128 | 0.263 | 0.193 | RNA-directed DNA polymerase inhibitor | 0.169 0.154 DBMET00308 0.193 0.11 DBMET02401 | DBMET02401 | |
| 0.113 | 0.258 | 0.183 | Lipoxygenase inhibitor | 0.183 0.159 DBMET00264 | DBMET00264 | |
| 0.077 | 0.242 | 0.368 | DNA methyltransferase I inhibitor | 0.368 0.012 DBMET02401 | DBMET02401 | |
| 0.101 | 0.273 | 0.126 | CC chemokine 6 receptor antagonist | 0.126 0.087 DBMET02401 | DBMET02401 | |
| 0.024 | 0.203 | 0.045 | Alpha 1L adrenoreceptor agonist | 0.045 0.024 DBMET00265 | DBMET00265 | |
| 0.077 | 0.257 | 0.405 | DNA methylase inhibitor | 0.405 0.01 DBMET02401 | DBMET02401 | |
| 0.034 | 0.221 | 0.101 | Adenosine A3 receptor antagonist | 0.101 0.026 DBMET02401 | DBMET02401 | |
| 0.097 | 0.291 | 0.263 | Hypoglycemic | 0.263 0.069 DBMET02401 | DBMET02401 | |
| 0.108 | 0.307 | 0.372 | DNA synthesis inhibitor | 0.173 0.164 DBMET00308 0.372 0.026 DBMET02401 | DBMET02401 | |
| 0.017 | 0.221 | 0.113 | Selectin antagonist | 0.063 0.047 DBMET00308 0.113 0.024 DBMET02401 | DBMET02401 | |
| 0.07 | 0.296 | 0.339 | Platelet antagonist | 0.339 0.041 DBMET02401 | DBMET02401 | |
| 0.109 | 0.342 | 0.318 | Vasodilator, coronary | 0.318 0.074 DBMET02401 | DBMET02401 | |
| 0.008 | 0.245 | 0.047 | Guanylate cyclase inhibitor | 0.047 0.024 DBMET02401 | DBMET02401 | |
| 0.04 | 0.298 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 DBMET02401 | DBMET02401 | |
| 0.056 | 0.336 | 0.191 | Hexokinase inhibitor | 0.191 0.041 DBMET02401 | DBMET02401 | |
| 0.141 | 0.422 | 0.317 | Calcium channel L-type activator | 0.317 0.143 DBMET00264 0.292 0.164 DBMET00308 | DBMET00264 | |
| 0.083 | 0.398 | 0.246 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.246 0.044 DBMET02401 | DBMET02401 | |
| 0.051 | 0.371 | 0.171 | Interleukin agonist | 0.171 0.148 DBMET02401 | DBMET02401 | |
| 0.043 | 0.393 | 0.102 | Adenylate kinase inhibitor | 0.102 0.065 DBMET02401 | DBMET02401 | |
| 0.025 | 0.41 | 0.166 | Uric acid excretion stimulant | 0.166 0.019 DBMET02401 | DBMET02401 | |
| 0.037 | 0.427 | 0.207 | Interleukin 1 antagonist | 0.207 0.03 DBMET00308 | DBMET00308 | |
| 0.011 | 0.431 | 0.032 | Purinergic P2Y2 antagonist | 0.032 0.025 DBMET02401 | DBMET02401 | |
| 0.057 | 0.499 | 0.186 | Cholesterol antagonist | 0.186 0.178 DBMET02401 | DBMET02401 | |
| 0.019 | 0.477 | 0.086 | UDP-glucose 4-epimerase inhibitor | 0.086 0.079 DBMET02401 | DBMET02401 | |
| 0.003 | 0.471 | 0.029 | Purinergic P2X agonist | 0.029 0.018 DBMET02401 | DBMET02401 | |
| 0.014 | 0.486 | 0.262 | Topoisomerase I inhibitor | 0.262 0.015 DBMET02401 | DBMET02401 | |
| 0.05 | 0.553 | 0.405 | Antibacterial | 0.405 0.075 DBMET02401 | DBMET02401 | |
| 0.015 | 0.53 | 0.101 | Estrogen receptor beta antagonist | 0.101 0.063 DBMET00264 | DBMET00264 | |
| 0.028 | 0.555 | 0.29 | Vasodilator | 0.29 0.052 DBMET02401 | DBMET02401 | |
| 0.078 | 0.606 | 0.214 | Interleukin 2 agonist | 0.214 0.166 DBMET02401 | DBMET02401 | |
| 0.033 | 0.569 | 0.281 | Transcription factor NF kappa B inhibitor | 0.281 0.106 DBMET02401 | DBMET02401 | |
| 0.004 | 0.549 | 0.02 | Adenosine A3 receptor agonist | 0.02 0.009 DBMET02401 | DBMET02401 | |
| 0.026 | 0.577 | 0.258 | Insulin secretagoues | 0.258 0.018 DBMET02401 | DBMET02401 | |
| 0.017 | 0.631 | 0.109 | Thioredoxin inhibitor | 0.109 0.039 DBMET00308 | DBMET00308 | |
| 0.051 | 0.681 | 0.432 | Antiinflammatory | 0.432 0.12 DBMET02401 | DBMET02401 | |
| 0.023 | 0.656 | 0.158 | Tumour necrosis factor alpha release inhibitor | 0.158 0.147 DBMET00308 | DBMET00308 | |
| 0.025 | 0.661 | 0.287 | Antithrombotic | 0.287 0.098 DBMET02401 | DBMET02401 | |
| 0.033 | 0.692 | 0.369 | Immunomodulator | 0.369 0.053 DBMET02401 | DBMET02401 | |
| 0.004 | 0.668 | 0.015 | Adenosine A2b receptor agonist | 0.015 0.009 DBMET02401 | DBMET02401 | |
| 0.003 | 0.671 | 0.037 | Adenosine A1 receptor agonist | 0.037 0.009 DBMET02401 | DBMET02401 | |
| 0.009 | 0.705 | 0.099 | Aminoacyl-tRNA synthetase inhibitor | 0.099 0.046 DBMET02401 | DBMET02401 | |
| 0.065 | 0.766 | 0.318 | Peptidyltransferase inhibitor | 0.318 0.019 DBMET02401 | DBMET02401 | |
| 0.007 | 0.73 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET02401 | DBMET02401 | |
| 0.001 | 0.768 | 0.014 | Purinergic receptor agonist | 0.014 0.011 DBMET02401 | DBMET02401 | |
| 0.001 | 0.768 | 0.014 | Purinergic P2 agonist | 0.014 0.011 DBMET02401 | DBMET02401 | |
| 0.023 | 0.797 | 0.182 | Hepatoprotectant | 0.182 0.078 DBMET02401 | DBMET02401 | |
| 0.01 | 0.819 | 0.251 | Angiogenesis stimulant | 0.251 0.07 DBMET02401 | DBMET02401 | |
| 0.003 | 0.849 | 0.017 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.017 0.008 DBMET02401 | DBMET02401 | |
| 0.012 | 0.863 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.037 DBMET02401 | DBMET02401 | |
| 0.012 | 0.875 | 0.318 | Immunosuppressant | 0.318 0.104 DBMET02401 | DBMET02401 | |
| 0.014 | 0.882 | 0.154 | DNA polymerase I inhibitor | 0.154 0.047 DBMET02401 | DBMET02401 | |
| 0.008 | 0.913 | 0.289 | Apoptosis agonist | 0.289 0.18 DBMET02401 | DBMET02401 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |